The results demonstrated that pathways involved in acute/chronic myeloid leukemia, non-small cell lung cancer, glioma, colorectal cancer, pancreatic cancer, renal cell carcinoma, prostate/bladder cancer and melanoma were more enriched in PTP1B-high express group. Here, PTPN1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.